Concepedia

Paul Kostenuik

PK

Statistics

Publications

3

Citations

90

H-Index

3

Active since

2005

Affiliations

Amgen (United States)(Current)

Paul Kostenuik is an author at Amgen (United States) specializing in renal pathology, nephrology, and chronic kidney disease.

Top concepts

Publications per year

2005–2011

3

Publications

3

The Receptor Activator of Nuclear Factor-κB Ligand Inhibitor Osteoprotegerin Is a Bone-Protective Agent in a Rat Model of Chronic Renal Insufficiency and Hyperparathyroidism

J. Padagas, M. Colloton, Victoria Shalhoub et al. · Calcified Tissue International · 2005 · 39 citations

, , +14

Host-derived RANKL is responsible for osteolysis in a C4-2 human prostate cancer xenograft model of experimental bone metastases

Colm Morrissey, Paul Kostenuik, Lisha G. Brown et al. · BMC Cancer · 2007 · 36 citations · Full text

OPG-Fc Treatment in Growing Pigs Leads to Rapid Reductions in Bone Resorption Markers, Serum Calcium, and Bone Formation Markers

Wolfgang Sipos, Philippe K. Zysset, Paul Kostenuik et al. · Hormone and Metabolic Research · 2011 · 15 citations

1–3 of 3